CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 98  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0528
LYS 10.0119
GLU 20.0082
LEU 30.0280
ARG 40.0332
CYS 50.0153
GLN 60.0358
CYS 70.0038
ILE 80.0146
LYS 90.0063
THR 100.0040
TYR 110.0062
SER 120.0157
LYS 130.0138
PRO 140.0085
PHE 150.0128
HIS 160.0290
PRO 170.0232
LYS 180.0528
PHE 190.0250
ILE 200.0126
LYS 210.0228
GLU 220.0263
LEU 230.0201
ARG 240.0080
VAL 250.0112
ILE 260.0197
GLU 270.0240
SER 280.0167
GLY 290.0424
PRO 300.0327
HIS 310.0214
CYS 320.0127
ALA 330.0247
ASN 340.0099
THR 350.0122
GLU 360.0165
ILE 370.0052
ILE 380.0072
VAL 390.0119
LYS 400.0134
LEU 410.0035
SER 420.0229
ASP 430.0285
GLY 440.0078
ARG 450.0240
GLU 460.0278
LEU 470.0227
CYS 480.0178
LEU 490.0106
ASP 500.0131
PRO 510.0163
LYS 520.0311
GLU 530.0190
ASN 540.0313
TRP 550.0084
VAL 560.0070
GLN 570.0125
ARG 580.0295
VAL 590.0196
VAL 600.0147
GLU 610.0132
LYS 620.0234
PHE 630.0186
LEU 640.0228
LYS 650.0344
ARG 660.0147
ALA 670.0426
GLU 680.0256
ASN 690.0287

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.